News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncoscience | As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression

Oncoscience

September 12, 2022
PRESS RELEASE: Dr. Blagosklonny published a new research commentary in Oncoscience, entitled, “As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression.” continue reading »

Oncotarget | Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma

News

September 8, 2022
PRESS RELEASE: A new research paper was published in Oncotarget, entitled, “Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma.” continue reading »

Aging | Systemic lipolysis promotes physiological fitness in Drosophila melanogaster

Aging

September 6, 2022
A new research paper was published in Aging Volume 14, Issue 16, entitled, “Systemic lipolysis promotes physiological fitness in Drosophila melanogaster.” continue reading »

Aging | Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells

Aging

September 1, 2022
PRESS RELEASE: A new research paper was published in Aging’s Volume 14, Issue 16, entitled, “Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells.” continue reading »

Genes & Cancer | Using Quantitative Immunohistochemistry in Patients at High Risk for Hepatocellular Cancer

Genes & Cancer

August 22, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on June 6, 2022, entitled, “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.” continue reading »